Cryosite: Appoints John Hogg as new CEO

  • Biotech company Cryosite (CTE) has appointed John Hogg as its new company CEO
  • John has been with the company since July 2018 and was promoted to General Manager of Operations in December 2019
  • He will begin his new role on Monday (October 19)
  • Bryan Dulhunty will step down from his current role as Executive Chairman to non-Executive Chairman
  • Then the future operational development and growth of Cryosite will now driven by John
  • On market close, Cryosite is down 5.88 per cent and is trading for 24 cents per share
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Cosegic Strengthens Financial Crime Expertise with Fintrail Acquisition

The acquisition enhances Cosegic's capabilities in combating financial crime.Highlights: Cosegic acquires Fintrail to enhance financial crime capabilities.The acquisition...

Keye Launches AI Co-Pilot for Private Equity Due Diligence

A game-changing tool to enhance efficiency in investment evaluations.Highlights: Keye introduces an AI-powered co-pilot for due diligence.Streamlines the...

Regulators Urged to Prioritize Gen AI Threats Over Quantum Computing Risks

Insights on the evolving regulatory landscape in fintech and AI.Highlights: Exchange Association emphasizes urgency on Gen AI regulatory...

Cryptocurrency Scam Losses Surge to $17 Billion in 2025, Fuelled by AI

Analysis reveals AI-driven schemes are escalating crypto fraud incidences.Highlights: Losses from cryptocurrency scams reached $17 billion in 2025.AI...